Opportunities center on ultrasensitive diagnostics, RNA aptamer-LNP therapies, AI-led discovery and bispecific conjugates, with Asia-Pacific rising despite IP and synthesis hurdles.Dublin, Sept.
Precision medicine, drug discovery and cell/gene therapies are driving adoption, creating opportunities in automation, spatial multi-omics, AI bioinformatics and clinical diagnostics.Dublin, Sept. 24, ...
Opportunities span AI-enabled discovery, multi-omics, precision medicine, advanced therapies, biomarker-led trials, data platforms, CRO partnerships and Asia-Pacific expansionDublin, Sept. 22, 2026 ...
University of Queensland researcher Dr Chris McMillan and Alison Gardiner. University of Queensland researcher Dr Chris McMillan wins inaugural BCEC LSQ Bio Innovation Bursary Brisbane Convention & ...
C57BL/6J (B6) and DBA/2J (D2) are two of the most commonly used inbred mouse strains in neuroscience research. However, the only currently available mouse genome is based entirely on the B6 strain ...
Gene expression and regulation are central to the survival and adaptation of Plasmodium falciparum. However, the interplay between transcriptional activity, Natural Antisense Transcripts (NATs), and ...
The differentially expressed genes were categorized according to known molecular functions. A proportion was associated with transcriptional control or had unknown functions: 49.0% (246/502) in DSCL ...
This article and associated images are based on a poster originally authored by Adam Buckle, Julia Unsicker and Iain McWilliam and presented at ELRIG Drug Discovery 2025 in affiliation with Arrayjet ...
BEA offers service for isolation and purification of RNA and DNA from biological samples. For RNA extractions, we use different versions of the QIAgen RNeasy protocol which are designed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results